Eisai (Singapore) Pte. Ltd.

Eisai (Singapore) Pte. Ltd. company information, Employees & Contact Information

Explore related pages

Eisai (Singapore) Pte. Ltd. email format Eisai (Singapore) Pte. Ltd. management contacts

Related company profiles:

A Leading Global Research and Development-Based Pharmaceutical Company Headquartered in Japan. Eisai has positioned neurology and oncology as its therapeutic areas of focus, where there are many diseases for which adequate treatments have yet to be established. In order to fulfill patients’ unmet needs, Eisai sets out a goal to be a “Medico Societal Innovator” or in other words, “a company that changes society through creating medicines and providing solutions”.

Company Details

Employees
21
Address
152 Beach Road, #15-07/08 Gateway East,singapore
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
https://eisai.com.sg/
Keywords
Neurology and Oncology.
HQ
Singapore
Competitors
Capsule Pharma Singapore, Eisai US, Eisai Co., Ltd., Boehringer Ingelheim, ICM Pharma, Hyphens Pharma International Ltd., Novartis Singapore, Zuellig Pharma, Pan-Malayan Pharmaceuticals, Servier Singapore.
Looking for a particular Eisai (Singapore) Pte. Ltd. employee's phone or email?

Eisai (Singapore) Pte. Ltd. Questions

News

Early Alzheimer’s Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC - Eisai

Early Alzheimer’s Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC Eisai

New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer’s Disease - Eisai

New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer’s Disease Eisai

Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment - Eisai

Eisai Selected as Supplier Engagement Leader, CDP's Highest Rating in the Supplier Engagement Assessment Eisai

Digital Asset Library - Eisai

Digital Asset Library Eisai

The First 80 Years | Eisai Co., Ltd. - Eisai

The First 80 Years | Eisai Co., Ltd. Eisai

Corporate Venture Capital - Eisai

Corporate Venture Capital Eisai

EISAI COMPLETES CONSTRUCTION OF ITS NEW INJECTION/RESEARCH BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN | News Release：2022 - Eisai

EISAI COMPLETES CONSTRUCTION OF ITS NEW INJECTION/RESEARCH BUILDING AT KAWASHIMA INDUSTRIAL PARK IN JAPAN | News Release：2022 Eisai

Eisai’s Efforts on Global Health ― An Interview of Scientists Working on Drug Discovery - Eisai

Eisai’s Efforts on Global Health ― An Interview of Scientists Working on Drug Discovery Eisai

Dementia - Eisai

Dementia Eisai

ANTIEPILEPTIC DRUG FYCOMPA® INJECTION FORMULATION LAUNCHED IN JAPAN - Eisai

ANTIEPILEPTIC DRUG FYCOMPA® INJECTION FORMULATION LAUNCHED IN JAPAN Eisai

Flow of R&D (Drug Creation Research) | Research and Development (R&D) - Eisai

Flow of R&D (Drug Creation Research) | Research and Development (R&D) Eisai

Compliance and Risk Management - Eisai

Compliance and Risk Management Eisai

hhceco (the hhc Concept + ecosystem) | Innovation - Eisai

hhceco (the hhc Concept + ecosystem) | Innovation Eisai

Initiatives for Improving Access to Medicines for Non-communicable Diseases - Eisai

Initiatives for Improving Access to Medicines for Non-communicable Diseases Eisai

Initiatives for Improving Access to Medicines - Eisai

Initiatives for Improving Access to Medicines Eisai

Discovering the Hidden Challenges: Understanding the Needs of the Alzheimer’s Disease Community - Eisai

Discovering the Hidden Challenges: Understanding the Needs of the Alzheimer’s Disease Community Eisai

Production and Logistics (Demand Chain Systems) - Eisai

Production and Logistics (Demand Chain Systems) Eisai

Alzheimer's Disease Treatment The Aricept R&D Story - Eisai

Alzheimer's Disease Treatment The Aricept R&D Story Eisai

Chapter 6 Breaking into the Top 20 Worldwide - Eisai

Chapter 6 Breaking into the Top 20 Worldwide Eisai

EISAI INC.'S U.S. HEADQUARTERS EARNS THREE KEY BUILDING CERTIFICATIONS - PR Newswire

EISAI INC.'S U.S. HEADQUARTERS EARNS THREE KEY BUILDING CERTIFICATIONS PR Newswire

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA - Biogen

Eisai Completes Submission of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease to the U.S. FDA Biogen

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease - Biogen

FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Biogen

Companies like Eisai (Singapore) Pte. Ltd.

Boehringer Ingelheim logo - Similar company to Eisai (Singapore) Pte. Ltd.

Boehringer Ingelheim

45.53K
Servier Singapore logo - Similar company to Eisai (Singapore) Pte. Ltd.

Servier Singapore

13
Zuellig Pharma logo - Similar company to Eisai (Singapore) Pte. Ltd.

Zuellig Pharma

6.64K
Pan-Malayan Pharmaceuticals logo - Similar company to Eisai (Singapore) Pte. Ltd.

Pan-Malayan Pharmace...

45
Hyphens Pharma International Ltd. logo - Similar company to Eisai (Singapore) Pte. Ltd.

Hyphens Pharma Inter...

332
Eisai US logo - Similar company to Eisai (Singapore) Pte. Ltd.

Eisai Us

2.88K
ICM Pharma logo - Similar company to Eisai (Singapore) Pte. Ltd.

Icm Pharma

39
Novartis Singapore logo - Similar company to Eisai (Singapore) Pte. Ltd.

Novartis Singapore

184
Eisai Co., Ltd. logo - Similar company to Eisai (Singapore) Pte. Ltd.

Eisai Co., Ltd.

672
Capsule Pharma Singapore logo - Similar company to Eisai (Singapore) Pte. Ltd.

Capsule Pharma Singa...

3

Top Eisai (Singapore) Pte. Ltd. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant